Cephalothin and cephaloridine therapy for bacterial meningitis

Fisher, Larry S.; Chow, Anthony W.; Yoshikawa, Thomas T.; Guze, Lucien B.; Fisher, L S; Chow, A W; Yoshikawa, T T; Guze, L B
May 1975
Annals of Internal Medicine;May75, Vol. 82 Issue 5, p689
Academic Journal
journal article
The efficacy of cephalothin and cephaloridine in the treatment of bacterial meningitis was evaluated from a review of 106 cases reported in the literature. Fifty-nine percent of 34 patients treated with intravenous cephalothin responded suboptimally; those receiving daily doses of 12 g or more fared significantly better (P less than 0.025). In contrast, 74% of 72 patients treated with cephaloridine responded favorably; those who received concomitant intrathecal cephaloridine responded significantly better (P less than 0.005). These findings indicate that cephalosporin therapy for bacterial meningitis, without concomitant intrathecal medication, is unreliable and that this is probably due to inadequate penetration of the antibiotics into cerebrospinal fluid. In penicillin-allergic patients with pneumococcal, meningococcal, and hemophilus meningitis, chloramphenicol is the agent of choice. For staphylococcal meningitis, intravenous cephalothin at doses of 12 g/day with additional intrathecal cephaloridine at doses of 12.5 to 50 mg/day should be administered concomitantly.


Related Articles

  • Surveillance of Bacterial Meningitis, Ethiopia, 2012-2013. Mihret, Wude; Lema, Tsehaynesh; Merid, Yared; Kassu, Afework; Abebe, Workeabeba; Moges, Beyene; Tenna, Admasu; Woldegebriel, Fitsum; Yidnekachew, Melaku; Mekonnen, Wondale; Ahmed, Arslan; Yamuah, Lawrence; Silamsaw, Mezgebu; Petros, Beyene; Oksnes, Jan; Rosenqvist, Einar; Ayele, Samuel; Aseffa, Abraham; Caugant, Dominique A.; Norheim, Gunnstein // Emerging Infectious Diseases;Jan2016, Vol. 22 Issue 1, p75 

    Among 139 patients with suspected bacterial meningitis in Ethiopia, 2012-2013, meningococci (19.4%) and pneumococci (12.9%) were the major disease-causing organisms. Meningococcal serogroups detected were A (n = 11), W (n = 7), C (n = 1), and X (n = 1). Affordable, multivalent meningitis...

  • A Decade of Herd Protection After Introduction of Meningococcal Serogroup C Conjugate Vaccination. Bijlsma, Merijn W.; Brouwer, Matthijs C.; Spanjaard, Lodewijk; van de Beek, Diederik; van der Ende, Arie // Clinical Infectious Diseases;Nov2014, Vol. 59 Issue 9, p1216 

    Nationwide laboratory surveillance data from the Netherlands (1998–2012) shows a decline of >93% in meningococcal serogroup C (MenC) invasive disease. Herd protection is responsible for >36% of MenC conjugate vaccine impact and lasts for ≥10 years.Background. Vaccination with...

  • TRENDS AND EPIDEMIOLOGICAL ASPECTS OF BACTERIAL MENINGITIS IN CHILDREN. dos Santos Ferreira, José Henrique; Alves Silva Gomes, Ayla Maritcha; de Oliveira, Conceição Maria; do Bonfim, Cristine Vieira // Journal of Nursing UFPE / Revista de Enfermagem UFPE;Jul2015, Vol. 9 Issue 7, p8534 

    No abstract available.

  • Safety and Efficacy of Cefazolin Sodium in the Management of Bacterial Infection and in Surgical Prophylaxis. kusaba, Tetsuro // Clinical Medicine: Therapeutics;2009, Issue 1, p1607 

    Cefazolin sodium is a first-generation cephalosporin antibiotic and has been used worldwide since the early 1970s. It is used for the treatment of bacterial infections in various organs, such as the respiratory tract, skin and skin structure, genital tract, urinary tract, biliary tract, and bone...

  • Bacterial Meningitis in Malawian Adults, Adolescents, and Children During the Era of Antiretroviral Scale-up and Haemophilus influenzae Type b Vaccination, 2000–2012. Wall, Emma C.; Everett, Dean B.; Mukaka, Mavuto; Bar-Zeev, Naor; Feasey, Nicholas; Jahn, Andreas; Moore, Mike; van Oosterhout, Joep J.; Pensalo, Paul; Baguimira, Kenneth; Gordon, Stephen B.; Molyneux, Elizabeth M.; Carrol, Enitan D.; French, Neil; Molyneux, Malcolm E.; Heyderman, Robert S. // Clinical Infectious Diseases;May2014, Vol. 58 Issue 10, pe137 

    Culture positive bacterial meningitis has fallen over a 12-year period in urban Malawi following Hib vaccination. Hib, NTS, and pneumococcal meningitis have fallen significantly in children. Pneumococcal meningitis has not fallen in adults; NTS and pneumococcal meningitis are...

  • Chryseobacterium indologenes Meningitis in a Healthy Newborn: A Case Report. Hendaus, Mohamed A.; Zahraldin, Khalid // Oman Medical Journal;Mar2013, Vol. 28 Issue 2, p133 

    Chryseobacterium indologenes is a rare cause of infection in infants. The majority of case reports belong to hospitalized infants with indwelling devices. We are presenting a rare case of Chryseobacterium indologenes meningitis in a healthy newborn with no neonatal intensive care unit admissions...

  • Lumbar puncture should not be performed in meningococcal disease. Nadel, Simon; Nadel, S // Archives of Disease in Childhood;Apr2001, Vol. 84 Issue 4, p375 

    Presents a letter to the editor with a message that lumbar puncture should not be performed in meningococcal disease.

  • Antibacterial evaluation of some organic compounds as potential inhibitors for glucosamine-6-phospate synthase. Vennila, Jasmine P.; John Thiruvadigal, D.; Kavitha, Helen P. // Journal of Pharmacy Research;2012, Vol. 5 Issue 4, p1963 

    The present paper deals with the antibacterial activity of some five organic compounds against gram positive bacteria such as Staphylococcus aureus, Streptococcus and Escherichia coli and Gram negative micro organisms such as Pseudomonas aeruginosa and Klebsiella pneumonia at 100 μg/mL...

  • Guidelines for managing acute bacterial meningitis. Moller, Kirsten; Skinhoj, Peter // BMJ: British Medical Journal (International Edition);05/13/2000, Vol. 320 Issue 7245, p1290 

    Editorial. Provides information on the standardized guidelines for managing adult with acute bacterial meningitis in Great Britain. Prevention of secondary cases; Effectiveness of antibiotics in acute bacterial meningitis treatment; Prognosis of meningitis.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics